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Abstract
Background: Epithelial to mesenchymal transition, especially to myofibroblasts, plays an important role in wound
healing, fibrosis, and carcinogenesis. Epidermal stem cells (EpSCs) are responsible for epidermal renewal and wound
re-epithelialization. However, it remains unclear whether and how EpSCs transdifferentiate into myofibroblasts or
myofibroblast-like cells (MFLCs). Here, we provide the first evidence showing that P311 induces EpSC to MFLC
transdifferentiation (EpMyT) via TGFβ1/Smad signaling.
Methods: Wound healing and mesenchymal features were observed in the P311 KO and P311 WT mouse model
of superficial second-degree burns. After the primary human or mouse EpSCs were forced to highly express P311
using an adenoviral vector, EpMyT was observed by immunofluorescence, real-time PCR, and western blot. The
activity of TGFβ1 and Smad2/3 in EpSCs with different P311 levels was observed by western blot. The TβRI/II
inhibitor LY2109761 and Smad3 siRNA were applied to block the EpMyT in P311-overexpressing EpSCs and
exogenous TGFβ1 was to restore the EpMyT in P311 KO EpSCs. Furthermore, the mechanism of P311 regulating
TGFβ1 was investigated by bisulfite sequencing PCR, luciferase activity assay, and real-time PCR.
Results: P311 KO mouse wounds showed delayed re-epithelialization and reduced mesenchymal features.
The human or mouse EpSCs with overexpressed P311 exhibited fusiform morphological changes, upregulated
expression of myofibroblast markers (α-SMA and vimentin), and downregulated expression of EpSC markers
(β1-integrin and E-cadherin). P311-expressing EpSCs showed decreased TGFβ1 mRNA and increased TGFβ1
protein, TβRI/II mRNA, and activated Smad2/3. Moreover, LY2109761 and Smad3 siRNA reversed P311-induced
EpMyT. Under the stimulation of exogenous TGFβ1, the phosphorylation of Smad2 and Smad3 in P311 KO EpSCs
was significantly lower than that in P311 WT EpSCs and the EpMyT in P311 KO EpSCs was restored. Furthermore,
P311 enhanced the methylation of TGFβ1 promoter and increased activities of TGFβ1 5′/3′ untranslated regions
(UTRs) to stimulate TGFβ1 expression. P311+α-SMA+ cells and P311+vimentin+ cells were observed in the
epidermis of human burn wounds. Also, P311 was upregulated by IL-1β, IL-6, TNFα, and hypoxia.
Conclusions: P311 is a novel TGFβ1/Smad signaling-mediated regulator of transdifferentiation in EpSCs during
cutaneous wound healing. Furthermore, P311 might stimulate TGFβ1 expression by promoting TGFβ1 promoter
methylation and by activating the TGFβ1 5′/3′ UTR.
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Background
Cutaneous wounds resulting from injuries such as trauma,
burns, surgery, and diabetes are common clinical prob-
lems. Inflammatory reactions, granulation tissue forma-
tion, and re-epithelialization are the three classic processes
during wound healing [1, 2]. Macrophages, neutrophils,
and lymphocytes participate in inflammatory responses
in wounds. Epidermal stem cells (EpSCs) and keratino-
cytes perform an essential role in re-epithelialization by
migrating from their niche towards the wound and then
undergoing proliferation and differentiation [3–5]. Fi-
broblasts and myofibroblasts have been suggested to be
the main functional cells in granulation tissue forma-
tion and wound contracture [6]. Myofibroblasts play
crucial roles during wound healing, but the healing
process can be compromised if the proliferation of
myofibroblasts is not properly regulated, which can, in
turn, lead to excessive scarring [7]. It is conventionally
assumed that myofibroblasts originate from fibroblasts
that develop from the mesoderm. However, some stud-
ies have shown that epithelial cells from the ectoderm
or endoderm can also transdifferentiate into myofibro-
blasts during pathological processes, for example, dur-
ing lung, liver, and kidney fibrosis and carcinogenesis
[8–10]. Epithelial–mesenchymal transition (EMT) is
characterized by the downregulation of epithelial
markers (e.g., E-cadherin) and the upregulation of myo-
fibroblast markers (e.g., α-SMA and vimentin). In skin,
epidermal cells are classically thought to perform their
role in myofibroblast formation by secreting transform-
ing growth factor beta 1 (TGFβ1), interleukin-1 (IL-1),
basic fibroblast growth factor (bFGF), tumor necrosis
factor alpha (TNFα), and other humoral factors that
regulate the fibroblast to myofibroblast differentiation
[11–13]. Recently, several studies have shown that
epidermal keratinocytes directly transdifferentiate into
fibroblasts when exposed to TGFβ1, IL-1β, TNFα, and
fetal bovine serum (FBS) [14–16]. However, the mech-
anisms involved in keratinocyte transdifferentiation
during wound healing are not fully understood. Import-
antly, keratinocytes are the daughter cells of EpSCs that
reside in the interfollicular region and EpSCs are primarily
responsible for the renewal of the epidermis and wound
re-epithelialization [17]. Therefore, it is important to in-
vestigate whether and how EpSCs transdifferentiate into
myofibroblasts or myofibroblast-like cells (MFLCs).
Using gene expression profiling and comparative prote-
omic analysis, we found previously that P311 (also known
as PTZ17 and neuronal protein 3.1) expression was dra-
matically increased in hypertrophic scars [18]. The high
level of expression of P311 in these tissues suggested that
it plays an important role in wound healing and scar
formation. P311 is a novel gene that encodes an 8-kDa
protein which contains several PEST (rich in proline (P),
glutamic acid (D), aspartic acid (E), and serine (S) or
threonine (T))-like domains and participates in the devel-
opment of neurons and smooth muscles [19]. Because
myofibroblasts are defined as specialized fibroblasts with
smooth muscle-like features, we hypothesized that P311
might also be involved in myofibroblast formation. In fact,
our and other studies have shown that P311 can induce
primary human fibroblasts [20] and fibroblast cell lines
[19, 21] to differentiate into myofibroblasts. We recently
found that P311 was highly expressed in EpSCs that are
located in the neo-epidermis and hair follicles during
wound healing [22] and that P311 promoted EpSC migra-
tion. However, the wound healing changes in P311 KO
mice and the role of P311 in EpSC to MFLC transdifferen-
tiation (EpMyT) remains unknown.
Previous studies on EMT have shown that TGFβ1 is a
factor that induces fibroblasts and epithelial cells to be-
come myofibroblasts. Active TGF-β1 is dissociated from
a latent-associated protein (LAP) complex known as
LAP-TGFβ1 which is cleaved from a large homodimeric
precursor (proTGFβ1). When active TGFβ1 binds its
specific receptors, it initiates downstream signaling path-
ways, such as the Smad pathway [23]. Several studies
have shown that P311 is a novel regulator of TGFβ1 in
fibroblasts and vascular smooth muscle cells [20, 21, 24].
In this study, we report the first evidence showing that
EpSCs can transdifferentiate into MFLCs in vitro and we
also show that this process is potentially regulated by
P311. Our study provides novel insight into the regula-
tion of transdifferentiation of EpSCs.
Methods
Human tissue sources
Paraffin blocks from surgically removed burn wounds
and spare normal skin transplants that were obtained
from five patients were selected from Department of
Pathology archival materials. The samples containing the
junctions between normal and burned skin were selected
in this study. All of the included five patients were in-
jured by flame or boiling water and the burn sites were
the limbs and trunk.
Animals and superficial second-degree burn mouse model
P311 KO mice were generated and genotyped as described
previously [25]. To create a second-degree thermal burn
injury, a scalding apparatus was applied using a perman-
ent temperature and pressure (YSL-5Q). A stainless steel
cylinder with an area of 2 cm2 was heated to 80 °C and
placed on the shaved dorsal skin for 3 seconds at a pres-
sure of 500 g [26]. Two wounds were produced on every
mouse, and eight mice were included in each group. The
wounds were imaged daily using a digital camera and ana-
lyzed using ImageJ software. Seven days after injury, the
entire wound, including 2 mm of surrounding normal
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skin, was harvested and separated into two halves across
the center. One half of the wound was processed for histo-
logical analysis. The other half was rapidly frozen in liquid
nitrogen for RNA and protein analysis.
Culture and characterization of human and mouse EpSCs
Human and mouse EpSCs were isolated from human
foreskin and newborn (day 0–2) mouse skin, respect-
ively, as described previously with some modifications
[17, 27, 28]. Briefly, the human and mouse skin tissues
were incubated in 0.5% Dispase II (04942078001; Roche)
in 0.9% NaCl at 4 °C overnight. The epidermal sheet was
carefully separated from the dermis, minced, and then
digested in 0.5% trypsin in PBS at 37 °C for 10 minutes.
The epidermal suspension was gently agitated to create
a single-cell suspension. The trypsin was inactivated in
calcium-free RPMI 1640 medium containing 10% che-
lexed FBS. The suspension was filtered through a 70-μm
cell strainer (352350; Falcon), and the cell suspension
was centrifuged at 800 rpm for 6 minutes. Human cells
were resuspended in complete medium containing kera-
tinocyte serum-free medium (K-SFM, 37010-022; Gibco),
human recombinant epidermal growth factor (0.18 ng/
ml), bovine pituitary extract (28 mg/ml), calcium chloride
(0.05 mM), and penicillin and streptomycin solution
(100 IU/ml, 15140122; Gibco). The complete medium for
mouse EpSCs also contained 10 ng/ml mouse epidermal
growth factor (354001; BD) and 10–10 M cholera toxin
(C9903; Sigma). The cells were seeded at a density of 105
cells/cm2 in plates or flasks that were coated with 100 μg/
ml type IV collagen (C5533; Sigma) and allowed to adhere
for 15 minutes at 37 °C. The nonadherent cells were dis-
carded, and the rapidly adhering cells were cultured in
complete medium at 37 °C in 5% CO2. The characterization
of the EpSCs was performed according to the methods
described by Kaur [29]. After the cells were cultured for
4 days, the EpSCs were digested and stained with
FITC-conjugated CD71 (561936 and 555536; BD) and
PE-conjugated CD49f (555736; BD) antibodies. Flow
cytometry data were acquired using an Attune Acoustic
Focusing Cytometer (Applied Biosystems, Life Tech-
nologies, CA, USA), and the data were analyzed using
FlowJo software (Tree Star Incorporation, USA).
Cell treatments
A replication-defective adenovirus vector encoding human
P311 and an empty control vector were prepared as de-
scribed previously [20]. At approximately 70% cell conflu-
ence, 1 × 107 PFU/ml of the viral suspension was added to
fresh medium. At 24 hours after transfection, the medium
was removed, and the cells were cultured in fresh medium
for an additional 48 hours. For the TGFβ1 inhibition ex-
periments, 5 μM LY2109761 (S2704; Selleck) or 100 nM
Smad3 siRNA or mock siRNA (siN05815122147; Ribobio)
was added to the medium at 24 hours after transfection,
and the EpSCs were harvested after 48 hours. The target
sequence of Smad3 siRNA was CCGTATGAGCTTCGT
CAAA. For the TGFβ1 mRNA stability analysis, 5 μg/ml
actinomycinD (1162400; Sigma) was added at 72 hours
after transfection, and the cells were subsequently har-
vested at the indicated time points. For the TGFβ1 restor-
ation and cytokine stimulation experiments, 10 ng/ml
exogenous TGFβ1 (PHG9214; Life Technologies), 10 ng/
ml IL-1β (AD1413073; R&D systems), 10 ng/ml IL-6
(406-ML-025; R&D systems), or 10 ng/ml TNFα (210-TA-
020; R&D systems) was added to EpSCs at 70% cell
confluence, and the cells were then cultured for 72 hours.
To induce hypoxia, EpSCs at 70% cell confluence were
cultured for 72 hours in a mionectic incubator set at 37 °C
with 5% CO2 and 2% O2.
Immunostaining and morphology
Cultured human and mouse EpSCs were washed in
warm PBS and fixed in 4% paraformaldehyde (PFA) for
25 minutes at room temperature. After the cells were
washed in PBS, they were blocked in 10% donkey
serum and then incubated with primary antibodies at
4 °C overnight. The formalin-fixed and paraffin-
embedded human and mouse skins were sectioned and
mounted on polylysine-coated slides. The slides were
submitted to deparaffinization and rehydration in xylene,
ethyl alcohol, and PBS according to a standard protocol.
Antigen retrieval was achieved via boiling in 10 mM cit-
rate buffer (pH 6.0) for 15 minutes, followed by blocking
and incubating with the antibodies already described. The
following primary antibodies were used: CY3-conjugated-
α-SMA (1:100, C6198; Sigma), E-cadherin (1:100, SC7870;
Santa Cruz), vimentin (1:200, ab92547; Abcam), P311
(1:100, BS0427R; Bioss), and phalloidin (1:1000, 77418-
1EA; Sigma). The corresponding secondary antibodies
were Alexa Fluor 488 (1:400, A21206; Life Technologies)
and Alexa Fluor 594 (1:400, A21207; Life Technologies).
Cell nuclei were labeled using DAPI (1:1000, D8417;
Sigma), and coverslips were mounted onto the slides using
Antifade Mounting Medium (P0126; Beyotime). For im-
munohistochemistry, the reactions were developed using
Biotin-Streptavidin HRP Detection Systems (SP9001;
ZSGB-Bio), and color reactions were performed using a
diaminobenzidine (DAB) kit (ZLI-9018; ZSGB-Bio). The
sections were counterstained with hematoxylin. The nega-
tive controls were performed in the same manner but
without the primary antibody. For double-staining experi-
ments, immunohistochemistry was first performed for
P311 as already described. The tissues were then incu-
bated with the antibodies for vimentin or α-SMA at 37 °C
for 1 hour. Subsequent steps were the same as those
already described. To quantify wound re-epithelialization,
sections from the center of the wounds were stained with
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HE and then imaged. The epidermal gaps and neo-
epidermal lengths were measured using ImageJ 1.48V
software (NIH, USA).
Western blot analysis
Mouse skins were ground in liquid nitrogen and homog-
enized using a Whole Cell Lysis Kit (KGP2100; Keygen)
containing RIPA lysis buffer, protease and phosphatase
inhibitor cocktails, and PMSF. Cell lysates were collected
at the indicated time points using the same lysis kit. The
skin and cell lysates were then centrifuged at 14,000 × g
for 15 minutes. The supernatants were collected, and
protein concentrations were determined using a BCA
Assay (23225; Pierce). Equal weights of protein were
mixed with SDS loading buffer and cell lysis buffer to
obtain equal protein concentrations and then boiled for
8 minutes. Proteins were subjected to electrophoresis in
10% SDS-PAGE gels at 100 V for approximately 2 hours.
The separated proteins were transferred electrophoretic-
ally to PVDF membranes (Millipore) at 100 V over
90 minutes. The membranes were blocked in 3% bovine
serum albumin in Tris-buffered saline containing 0.1%
Tween20 (TBST) for 3 hours at room temperature and
then incubated with primary antibodies diluted in
blocking buffer at 4 °C overnight. The following pri-
mary antibodies were used: α-SMA (1:2000, ab5694;
Abcam), E-cadherin (1:500, SC7870; Santa Cruz),
vimentin (1:2000, ab92547; Abcam), β1-integrin (1:500,
SC374429; Santa Cruz), TGFβ1 (1:2000, NB100-91995;
Novus), P-Smad2 (1:2000, 3108S; Cell Signaling Technol-
ogy), Smad2 (1:2000, 5339S; Cell Signaling Technology),
P-Smad3 (1:2000, 9520S; Cell Signaling Technology),
Smad3 (1:2000, 9523S; Cell Signaling Technology), and
GAPDH (1:10,000, KC-5G4; Kangchen). After the mem-
branes were washed in TBST six times for 5 minutes
each, they were incubated with horseradish peroxidase-
conjugated secondary antibodies at room temperature
for 1 hour and then washed again. Finally, the signal
was developed using an enhanced chemiluminescence
(ECL) detection kit (35055; Pierce) and detected using
a Molecular Imager ChemiDoc TMXRS+ Imaging Sys-
tem (BioRad). The protein band densities were analyzed
using Image Pro-Plus 6.0 software (Media Cybernetics).
RNA isolation and real-time PCR
Total RNA was extracted from mouse skin and primary
EpSCs with the RNeasy Mini Kit (74104; Qiagen), and
cDNA was synthesized with a cDNA Synthesis Kit (FSK-
100; Toyobo). Real-time PCR was performed with a SYBR
Green Master Mix (QPK-201; Toyobo) on a 7500 Real
Time PCR System (Applied Biosystems Instruments). The
primers used are presented in Additional file 1: Table S1.
The following reaction conditions were used: predenatura-
tion at 95 °C for 2 minutes; and 35 cycles of denaturation
at 95 °C for 30 seconds, annealing at 61 °C for 15 seconds,
and extension at 72 °C for 32 seconds. GAPDH or HPRT
was used as the internal control.
DNA extraction and bisulfite sequencing PCR
Genomic DNA was extracted from mouse EpSCs using
a genomic DNA kit (DP304; TIANGEN). The DNA
(1 μg/sample) was converted using an Epitect Bisulfite
kit (59104; Qiagen) according to the manufacturer’s
instructions. The DNA sequence of the total TGFβ1
promoter (–2000 to +1000) was downloaded from
Genebank. The CpG island region and its primer were
acquired using Methyl Primer Express (Applied Biosys-
tems Instruments). The bisulfite-converted genomic
DNA fragments belonging to the CpG island region (–544
to +990) were then amplified using PCR. The PCR prod-
ucts were resolved on 1% agarose gels, purified, and then
cloned with a pMD-19T Vector Cloning Kit (6013;
Takara). Five colonies from each ligation were selected
randomly and sequenced. The methylation status of each
CpG site was analyzed on the QUMA website (http://
quma.cdb.riken.jp/).
Luciferase reporter assay
For the promoter activity assay, the promoter of human
TGF-β1 (–1328 to + 812) was cloned into the pGL3-
basic plasmid (E1751; Promega). The primers used to
clone the TGF-β1 promoter were 5′-GATTCGACGCG
TAGATCACTTTGGCTGCTG-3′ and 5′-TAGACCAG
ATCTGAGCGCGAACAGGGC-3′. For the untranslated
region (UTR) binding assay, the 5′ and 3′ UTRs of TGF-
β1 were inserted into the firefly luciferase pmirGLO ex-
pression vector (E1330; Promega). The primers used to
amplify the TGF-β1 UTR were: 5′ UTR, 5′-CTCCCTCC
CACCTCCCTCCG-3′ and 5′-GGCCAGGCGTCAGCA
CCAGTAG-3′; and 3′ UTR, 5′-CCGCTGCCCATCGTG-
TACTA-3′ and 5′-GGCCTGAACTACTATCTTTTATT
GTCTT-3′. Mouse EpSCs were seeded on 12-well plates
and transfected with an adenovirus encoding P311. At
24 hours after P311-adenovirus transfection, the cells were
transfected with the promoter plasmid or UTR plasmid
using Lipofectamine2000 for the promoter or UTR ana-
lysis, respectively. After 48 hours, luciferase activity was
determined using a Dual Luciferase Assay System (E2940;
Promega) and the results were normalized to the internal
control Renilla luciferase activity according to the manu-
facturer’s protocol.
ELISA
The total amount of TGFβ1 in the cell culture medium
was detected by a Quantikine ELISA kit (MB100B; R&D
systems) with the EpSC culture supernatant according to
the manufacturer’s instructions. Briefly, the culture
supernatant was collected by centrifuging the solution at
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1000 rpm for 10 minutes. The cell culture supernatant
was acidified to obtain total TGFβ1 and then allowed to
bind to coated antibodies at room temperature for
2 hours. HRP-conjugated TGFβ1 antibodies were incu-
bated at room temperature for 1.5 hours followed by the
addition of chromogen tetramethylbenzidine (TMB) and
stop solution. Absorbance was recorded at 450 and
540 nm.
Statistical analysis
Statistical comparisons were performed using Student's t
tests or one-way ANOVA by Graphpad Prism 6.0 soft-
ware (Graphpad Software Inc.). The data are presented
as the mean ± standard error of the mean (SEM). In all
cases, P < 0.05 was considered to indicate statistical
significance.
Results
Loss of P311 results in altered wound healing kinetics
To determine whether P311 could affect burn wound
healing, superficial second-degree thermal burn wounds
were created in P311 KO mice and sex-matched and age-
matched P311 WT mice. On days 5 and 7 post injury, the
wound areas in the P311 WT mice were reduced to 69%
and 47% of the initial wound area, respectively. However,
the average wound area in the P311 KO mice was larger
than that in the P311 WT mice (91% and 69% on days 5
and 7, respectively; Fig. 1a, b). HE staining showed that
wound re-epithelialization was clearly slower in the P311
KO mice than in the P311 WT mice on days 4 and days 7
post injury (Fig. 1c). The width of each wound in the P311
KO mice was significantly larger than that in the P311
WT mice (P311 KO, 9.87 mm vs P311 WT, 6.82 mm on
days 7, P < 0.05). Moreover, the average neo-epidermal
length in the P311 KO mice was significantly shorter than
that in the P311 WT mice (Fig. 1d; P311 KO, 1.48 mm vs
P311 WT, 2.14 mm, P < 0.05). These results indicate that
the deletion of P311 resulted in delayed burn wound
healing.
Mesenchymal features are reduced in P311 KO mouse
burn wounds
Next, we analyzed the mesenchymal features of the cells
in mouse burn wounds. IHC staining for vimentin
showed that the proximal and distal neo-epidermis in
P311 WT mice were both thicker than those in P311
KO mice. Moreover, the expression of vimentin in the
proximal and distal neo-epidermis of P311 KO mice was
also lower than that in P311 WT mice (Fig. 2a). However,
we did not observe specific α-SMA expression in P311
WT or P311 KO mouse wounds (Additional file 2: Figure
S1). The results of real-time PCR showed that the mRNA
levels of vimentin, the EMT agonist TGFβ1, and the
EMT-specific markers Snail2 and Twist1 were significantly
higher in normal skin and burn wounds in P311 WT
mice than those in P311 KO mice (Fig. 2b), indicating
that reprogramming had occurred at the transcriptional
level. Western blot analyses showed that the burn wounds
contained higher levels of β1-integrin than normal skin
samples (P < 0.05). The expression of β1-integrin was sig-
nificantly higher in burn wounds in the P311 KO mice
than that in the P311 WT mice (Fig. 2c, d). The P311 WT
burn wounds showed significantly increased levels of
vimentin and active TGFβ1 than the normal skin but the
P311 KO mice showed no significant difference. The ex-
pression levels of vimentin and active and LAP-bound
TGFβ1 in P311 KO normal skin or burn wounds were
significantly lower than those in P311 WT normal skin or
burn wounds (Fig. 2c, d). However, there was no signifi-
cant difference between E-cadherin levels in P311 KO
mice and P311 WT mice, and the E-cadherin levels in
normal skin were significantly higher than those in burn
wounds (Fig. 2c, d). Taken together, these results hint at a
possible relationship between P311 and mesenchymal
features in mouse burn wounds.
P311 induces a myofibroblast-like phenotype in primary
mouse and human EpSCs
To determine the effect of P311 on EpMyT, we evaluated
primary mouse EpSCs for their EpMyT potential following
P311 induction. Mouse EpSCs were isolated from neonatal
mice. Cultured cells showed a typical cobblestone-like
morphology and were identified as EpSCs using flow
cytometry. More than 95% of the cultured cells were
CD71lowCD49fhigh EpSCs (Additional file 2: Figure S2).
The isolated and cultured EpSCs were transfected with an
adenoviral expression vector that encoded P311 and GFP.
The transfection efficiency of this vector was confirmed by
flow cytometry and immunofluorescence (Additional file
2: Figure S3). After 72 hours, the EpSCs began to show
pronounced morphological changes. These changes in-
cluded loosened cell–cell contacts, increased cell volumes,
and a fusiform and well-spread morphology that resem-
bled myofibroblasts (Additional file 2: Figure S3A). The
control EpSCs continued to display a typical cobblestone
appearance. To confirm that P311 induced EpMyT, im-
munofluorescence, real-time PCR, and western blot assays
were performed to detect EpMyT-related markers. After
P311 induction, α-SMA was observed in the cytoplasm of
the EpSCs, especially in elongated cells (Fig. 3a). Most
of the EpSCs expressed vimentin in the perinuclear re-
gion (Fig. 3a). Moreover, E-cadherin levels were clearly
decreased (Fig. 3a). P311 also induced a dramatic
reorganization of the F-actin cytoskeleton, which showed
stress fibers and a lamellipodia-like organization. However,
the control group EpSCs showed a typical cortical
organization that was typical of epidermal cells (Fig. 3b).
Real-time PCR showed that the P311-transfected EpSCs
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contained significantly more α-SMA mRNA than the
vector-transfected EpSCs (Fig. 3c; P < 0.05). Consistent
with these results, the α-SMA and vimentin protein
levels in the P311-expressing EpSCs were 2.69-fold and
1.72-fold higher, respectively, than their levels in the
control vector-transfected cells (P < 0.05). The protein
levels of E-cadherin and β1-integrin protein levels were
32% and 68% lower, respectively, than their levels in the
control vector-transfected cells (P < 0.05; Fig. 3d). We
determined that these effects were ubiquitous in human
EpSCs (Additional file 2: Figure S4). We also found that
P311 promoted EpSC migration (Additional file 2: Figure
S5A, B) and induced collagen I and MMP2 expression
(Additional file 2: Figure S5C) but had no significant effect
on contraction (Additional file 2: Figure S5D). Together,
these results show that P311 can induce mouse and hu-
man EpSCs to undergo transdifferentiation into MFLCs,
not the typical myofibroblasts.
Fig. 1 Loss of P311 resulted in altered wound healing kinetics. Superficial second-degree thermal burn wounds were created in the skin of P311
WT and P311 KO mice. a Wounds were imaged after the wounding was performed. Representative wounds are shown on days 1, 5, and 7. Dotted
circles indicate the wound border. b Macroscopic quantification of the wound area. Data expressed as a fraction of the initial wound area (day 0).
Error bars represent SEM, n = 8 per group, Student’s t test, *P < 0.05. c Histological quantification of the wound width (left) and the neo-epidermal
length (right) was performed for the wounds on days 4 and 7. Wound width defined as the distance between one leading edge and another
leading edge in the same wound. Neo-epidermal length defined as the distance from the wound margin to the leading edge on the same side
of one wound. *P < 0.05 for P311 WT vs P311 KO. d Wound re-epithelialization on day 7 using HE staining. Representative images are shown. Red
arrow, wound margin; green triangle, leading edge of the neo-epidermis (Color figure online)
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Fig. 2 Mesenchymal features in P311 WT and P311 KO mouse burn wounds. a Vimentin expression in the proximal and distal neo-epidermis of
P311 WT and P311 KO mice was analyzed using immunohistochemistry. Proximal neo-epidermis was defined as the tongue of the neo-epidermis,
and distal neo-epidermis was defined as the epidermis at the margin of the wound. Scale bar, 25 μm. b mRNA levels of vimentin, TGFβ1,
Snail2, and Twist1 were detected using real-time PCR in P311 WT and P311 KO mouse burns and normal skin samples. c Western blot analysis
demonstrating the protein levels of β1-integrin, vimentin, E-cadherin, and active and LAP-bound TGFβ1 in P311 WT and P311 KO mouse burns
and normal skin samples. d Relative densities of the target proteins were standardized to the expression of GAPDH. Data are shown as the mean
± SEM, Student’s t test; *P < 0.05 and **P < 0.01 for P311 WT vs P311 KO; #P < 0.05 and ##P < 0.01 for normal skin vs burned wounds
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Fig. 3 P311 induced a myofibroblast-like phenotype in primary mouse EpSCs. a Immunofluorescence for α-SMA (upper), vimentin (middle), and
E-cadherin (lower) in EpSCs at 72 hours after P311 transfection (left) and control vector transfection (right). α-SMA, vimentin, and E-cadherin were
labeled using AF594 (red), and nuclei were stained with DAPI (blue). Representative images from four independent experiments are shown. Scale
bar, 25 μm. b Immunofluorescence for F-actin in EpSCs. TGFβ1 served as the positive control. F-actin was labeled by Rhodamine (red), and nuclei
were stained with DAPI (blue). Details for the observed cell morphologies are shown highlighted in the interior box and illustrated in the lower
panel. Scale bar, 20 μm. c The mRNA level of α-SMA was determined in P311-expressing cells and control vector-expressing cells using real-time
PCR (n = 4). d Western blot analysis for α-SMA, vimentin, β1-integerin, and E-cadherin in P311-transfected and control vector-transfected EpSCs.
Representative blots from four independent experiments are shown in the top panel. Bottom panel shows the quantification of protein levels,
which was obtained using densitometry (n = 4). Data are represented as mean ± SEM, Student’s t test, *P < 0.05 and **P < 0.01 in the P311-transfected
group vs the control vector-transfected group (Color figure online)
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Fig. 4 (See legend on next page.)
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P311-induced EpMyT is mediated by TGFβ1/Smad
signaling
Because TGFβ1/Smad signaling has ubiquitous effects
on cell biology and wound healing, we sought to deter-
mine whether P311-induced EpMyT was mediated by
TGFβ1/Smad signaling in primary mouse EpSCs. First,
the effect of P311 on TGFβ1 expression was investi-
gated using western blot analysis and real-time PCR.
The results showed that in P311-expressing EpSCs, the
levels of the LAP-bound and active forms of the TGFβ1
protein were significantly higher by 4.21-fold and 6.89-
fold, respectively, than the levels in the control vector-
transfected cells (Fig. 4a). The level of TGFβ1 mRNA
was decreased in P311-expressing EpSCs (Fig. 4b).
Meanwhile, in the P311-expressing EpSCs, the mRNA
levels of TβRI and TβRII were also upregulated by
1.72-fold and 2.22-fold, respectively, compared with
their levels in the control vector-transfected cells
(Fig. 4c). Second, to evaluate the contribution of TGFβ1
to P311-induced EpMyT, we introduced LY2109761, a
specific small molecule inhibitor of TβRI/II kinase [30].
After LY2109761 was added for 72 hours, the P311-
expressing EpSCs lost their myofibroblast morphology
and became similar to the control vector-transfected cells
(Fig. 4d). Immunofluorescence showed that LY2109761
decreased the number of α-SMA+ EpSCs and increased
the number of E-cadherin+ EpSCs in the P311-transfected
cells (Fig. 4e). Quantitative analysis showed that the per-
centage of α-SMA+ cells in the P311-expressing EpSCs
was significantly decreased from 40% to 8% in the cells
grown in the presence of LY2109761, whereas the per-
centage of E-cadherin+ cells significantly increased from
8% to 43% when cells were incubated in the presence of
LY2109761 (Fig. 4f). Consistent with these results, the in-
creases in the levels of the α-SMA and vimentin proteins
in the P311-expressing EpSCs were significantly inhibited
by LY2109761, whereas the decrease in the levels of the E-
cadherin and β1-integrin proteins was significantly re-
stored by LY2109761 (Fig. 4g). Also, the increased expres-
sion of collagen I and MMP2 in P311-expressing EpSCs
were inhibited by LY2109761 (Additional file 2: Figure
S5C). Third, the levels of phosphorylated Smad2 and
Smad3 were significantly increased in P311-expressing
EpSCs. However, the phosphorylation of Smad2 and
Smad3 was almost completely inhibited by LY2109761
and total Smad2 and Smad3 were not obviously chan-
ged (Fig. 4h and Additional file 2: Figure S6A). Fourth,
the specific Smad3 siRNA blocked the P311-induced
EpMyT. The inhibitory effect of Smad3 siRNA was
confirmed by western blot, which showed that the
Smad3 protein level was decreased by over 50% and the
phosphorylation of Smad3 was nearly completely inhib-
ited (Fig. 4i and Additional file 2: Figure S6B). Com-
pared with the P311-overexpressed EpSCs and mock
siRNA group, the P311-overexpressed EpSCs with
Smad3 siRNA exhibited significantly decreased α-SMA
and increased E-cadherin (Fig. 4i). Fifth, the addition of
exogenous TGFβ1 restored EpMyT in P311 KO EpSCs.
The total concentration of TGFβ1 in the culture
medium of P311 KO EpSCs was detected using ELISA
and found to be significantly lower than the concentra-
tion in P311 WT EpSCs (Fig. 4j). The level of the α-
SMA protein was lower in the P311 KO EpSCs than in
the P311 WT EpSCs but the difference was not signifi-
cant. In rescue experiments, we found that the level of
α-SMA was significantly increased in both P311 KO
EpSCs and P311 WT EpSCs (P < 0.05, compared with
the PBS group) when 10 ng/ml TGFβ1 was added to
the medium for 72 hours. Although P311 WT EpSCs
continued to express more α-SMA than P311 KO
(See figure on previous page.)
Fig. 4 P311-induced EpMyT is mediated by TGFβ1/Smad signaling. a Western blot analysis showing expression of LAP-TGFβ1 and active TGFβ1
in primary mouse EpSCs. Relative densities of target proteins are also shown in comparison with the density of GAPDH. **P < 0.01. b Real-time
PCR showing TGFβ1 mRNA levels in P311-transfected and control vector-transfected EpSCs. *P < 0.05. c Real-time PCR showing TβRI and TβRII
mRNA levels in P311-transfected and control vector-transfected EpSCs. *P < 0.05 and **P < 0.01. d Phase-contrast microscopic observations of cell
morphology 72 hours after the EpSCs were transfected with P311-containing vectors either with or without 5 μM LY2109761. e Immunofluorescence
was performed to determine the expression of α-SMA (upper) and E-cadherin (lower) in EpSCs at 72 hours after transfection with P311 (left), the control
vector (middle), and P311 with LY2109761 (right). α-SMA and E-cadherin were labeled using AF594 (red), and nuclei were stained using DAPI (blue).
Scale bar, 25 μm. f Quantification of α-SMA+ and E-cadherin+ cells in an average of five regions. **P < 0.01 for P311 vs control vector; ##P < 0.01 for
P311 vs P311 + LY2109761. g Western blot analysis was performed to determine α-SMA, vimentin, β1-integrin, and E-cadherin levels. *P < 0.05 and **P
< 0.01 for P311 vs control vector; and #P < 0.05 and ##P < 0.01 for P311 vs P311 + LY2109761. h Western blot analysis showing total and phos-
phorylated levels of Smad2 and Smad3 in primary EpSCs. LY2109761 was observed to have an inhibitory effect on Smad signals. *P < 0.05 and
**P < 0.01 for P311 vs control vector; and ##P < 0.01 for P311 vs P311 + LY2109761. i Western blot analysis was performed to determine α-SMA,
E-cadherin, and total and phosphorylated Smad3 levels after stimulation of Smad3 siRNA.*P < 0.05 and **P < 0.01 for P311 or P311 + mock siRNA vs
the control vector; and ##P < 0.01 for P311 + Smad3 siRNA vs P311 or P311 + mock siRNA. j ELISA showing the level of total TGFβ1 in the culture su-
pernatants of P311-transfected and control vector-transfected EpSCs. *P < 0.05. k Western blot analysis showing the expression of α-SMA in primary
P311 WT and P311 KO EpSCs after the cells were incubated with or without TGFβ1 treatment. *P < 0.05 and **P < 0.01 relative to PBS control;
##P < 0.01 relative to P311 KO cells treated with TGFβ1. l Western blot analysis was performed to determine the total and phosphorylated Smad3 levels
in P311 KO and P311 WT EpSCs with or without exogenous TGFβ1. Data shown as the mean ± SEM. **P < 0.01 relative to PBS control; #P < 0.05 relative
to P311 KO cells treated with TGFβ1 (Color figure online)
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EpSCs following TGFβ1 stimulation (P < 0.05), the
P311 KO EpSCs that were stimulated with TGFβ1 con-
tained almost the same level of α-SMA protein as the
P311 WT EpSCs that were not stimulated with TGFβ1
(P > 0.05; Fig. 4k). Sixth, the phosphorylation of Smad2
and Smad3 in P311 KO EpSCs was significantly lower
than that in P311 WT EpSCs with the stimulation of
exogenous TGFβ1 (Fig. 4l). However, the difference of
total Smad2 and Smad3 between P311 WT and P311
KO EpSCs was not significant (Additional file 2: Figure
S6C). In conclusion, these results indicate that TGFβ1/
Smad signaling is a downstream mediator of P311-
induced EpMyT.
P311 may stimulate TGFβ1 expression by promoting its
promoter methylation and UTR activity
To determine the mechanism by which P311 reduced
TGFβ1 mRNA levels but elevated TGFβ1 protein levels,
the effects of P311 on TGFβ1 transcription (including
promoter activity, DNA methylation, and mRNA stability)
and translation were analyzed. A luciferase reporter
analysis showed that P311 had no effect on TGFβ1
promoter activity (Additional file 2: Figure S7). A
DNA sequence analysis revealed that there is a CpG
island in the proximal promoter region of TGFβ1 ran-
ging from –544 to +990 relative to its transcription
start site (Fig. 5a). Bisulfite sequencing results showed
that the number of methylated CpG sites in the
P311-expressing EpSCs was higher than the number
in the control vector-transfected cells (Fig. 5b). The
effect of P311 on TGFβ1 translation was detected
using a luciferase UTR expression system that
included the TGFβ1 5′ and 3′ UTRs (Fig. 5c). The
results showed that EpSCs which expressed P311 at
high levels exhibited higher levels of luciferase activity
than were exhibited by the control vector-transfected
Fig. 5 P311 promoted TGFβ1 promoter methylation and UTR activity. a Diagram of the CpG island in the mouse TGFβ1 proximal promoter
ranging from –544 to +990 relative to the transcription start site. Vertical bars, CpG site; thick horizontal bar, CpG island. b DNA methylation status
of the CpG island was analyzed in P311-transfected and control vector-transfected mouse EpSCs using bisulfite sequencing PCR. Solid circles,
methylated cytosine residues; empty circles, unmethylated cytosine residues. c pmirGL0 UTR luciferase reporter constructs. d Luciferase reporter
analysis of the TGFβ1 5′ and 3′ UTRs in mouse EpSCs that were transfected with a P311 adenovirus or an empty control vector (n = 3 per group).
e TGFβ1 mRNA degradation curves. Actinomycin D was added to mouse EpSCs that were transfected with P311 or an empty control vector. The
amount of TGFβ1 mRNA was normalized to the initial value at 0 hours (n = 4 per group). Data shown as mean ± SEM, Student t test, *P < 0.05,**P<0.01.
UTR untranslated region
Li et al. Stem Cell Research & Therapy  (2016) 7:175 Page 11 of 17
cells in all of the luciferase UTR expression systems
(Fig. 5d). After actinomycin D was added, no signifi-
cant difference was found between the TGFβ1 mRNA
degradation in P311-expressing EpSCs and in the
control vector-transfected cells (slope: vector, –0.112
vs P311, –0.0805, P = 0.4531; Fig. 5e). Hence, P311
may stimulate TGFβ1 expression by promoting its
promoter methylation and UTR activity.
Mesenchymal features in the epidermis might be
associated with P311 activity in human burn wounds
To further explore whether there is a relationship between
P311 and EMT in vivo, we detected P311 levels and
analyzed mesenchymal features in human burn wounds.
First, we performed IHC for P311, vimentin, and α-SMA
on serial sections of human burn wounds and normal skin
samples. The results showed that while many vimentin+
and α-SMA+ cells were observed in the epidermis of burn
wounds, few such cells were observed in the normal
epidermis. Moreover, P311 was broadly expressed in the
epidermis of burn wounds, in which it was expressed
near to vimentin-expressing and α-SMA-expressing
cells (Fig. 6a). Second, double staining for P311 plus
vimentin or α-SMA was performed to determine whether
P311 is expressed in transformed cells. P311+α-SMA+ cells
and P311+vimentin+ cells were observed in the epidermis
of human burn wounds (Fig. 6b), suggesting that P311 is
expressed in α-SMA+ and vimentin+ epidermal cells.
These results thus suggest that mesenchymal features in
the epidermis might be associated with P311 activity in
human burn wounds.
P311 is upregulated by several common injury signals
To identify which factors promote P311 expression in burn
wounds, we analyzed the effects of several common injury
signals, including IL-1β, IL-6, TNFα, and hypoxia, on P311
in mouse EpSCs. The P311 mRNA level was significantly
increased by the stimulation of IL-1β, IL-6, TNFα, and hyp-
oxia (Fig. 7a). Among the tested factors, IL-1β and TNFα
increased P311 expression by more than 40-fold, which was
the most effective level of initiation. Hypoxia and IL-6 in-
creased the expression of P311 by 7.58-fold and 4.05-fold,
Fig. 6 Expression patterns of vimentin, α-SMA, and P311 in the epidermis of human burn wounds. a Immunohistochemical staining for vimentin,
α-SMA, and P311 was performed using serial sections of human burn wounds and normal skin. For the negative control, the primary antibodies
were replaced with PBS. Scale bar, 25 μm. b Double-labeling for P311 with vimentin or α-SMA was performed using human burn wound tissues.
*Double-labeled cells in the epidermis. Cells are shown magnified in the right panel. Scale bar, 25 μm
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respectively. These results suggest that cytokines and a hyp-
oxic microenvironment might be initiators of P311
expression.
Discussion
Transdifferentiation of epithelial cells into mesenchymal
cells is essential to the development of fibrosis and
Fig. 7 P311 was upregulated by several common injury signals. a Primary mouse EpSCs were stimulated using 10 ng/ml IL-1β, IL-6, or TNFα or
cultured in 2% O2 for 72 hours. Total RNA was extracted from the cells and analyzed using real-time PCR (n = 4 per group). Data shown as mean
± SEM, Student’s t test; *P < 0.05 and **P < 0.01 vs control group. b Model illustrating that P311 is involved in regulating the transdifferentiation of
EpSCs into MFLCs via a TGFβ1-dependent process. In a normal state, TGFβ1 transcription is steady but TGFβ1 mRNA is poorly translated because
it has long 5′/3′ UTRs. When EpSCs are stimulated with cytokines or hypoxia, P311 is upregulated. Although P311 slightly decreases TGFβ1 transcription
by enhancing the methylation of the TGFβ1 promoter, P311 significantly increases the expression of the TGFβ1 protein by activating its 5′/3′ UTRs.
Expression of TβRI/II and activity of Smad2/3 are subsequently enhanced indirectly by higher levels of active TGFβ1 or directly by P311. Smad2/3 is
then translocated into the nucleus, where it upregulates myofibroblast markers (e.g., vimentin and α-SMA) and downregulates EpSC markers
(e.g., E-cadherin and β1integrin) to promote the transdifferentiation of EpSCs into MFLCs. UTR untranslated region
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cancer progression. In the kidneys, EMT is a classic
source of myofibroblasts and fibroblasts during renal
fibrogenesis. However, little is known regarding the roles
performed by and regulation of EpMyT during skin
wound healing. Recent studies using rat kidney epithelial
cell lines have shown that P311 may promote IL-1α-
induced EMT via a TGFβ1-independent pathway [31] and
that it may inhibit TGFβ1-induced EMT by blocking the
Smad/ILK pathways [32]. Furthermore, our recent in-vivo
study showed that P311 promotes renal fibrosis via the
TGFβ1/Smad signaling [33]. These controversial results re-
vealed that the roles played by and mechanisms involving
P311 in cell biology might be cell and microenvironment
specific. However, it remains unclear whether P311 directly
induces EpSCs to transdifferentiate into MFLCs. To our
knowledge, this is the first study to link P311 with the dif-
ferentiation potential of stem cells, in which it increases
the transdifferentiation of EpSCs into MFLCs. Accord-
ingly, we found that P311 induced EpSCs to transdiffer-
entiate into MFLCs via a TGFβ1-mediated process in
vitro. Furthermore, our study also suggests that P311
might regulate TGFβ1 expression by promoting TGFβ1
promoter methylation at the transcriptional level and
by activating the TGFβ1 5′/3′ UTRs at the translational
level. Moreover, we provide evidence showing that
common injury signals (including cytokines and
hypoxia) might also promote the expression of P311.
Importantly, the deletion of P311 resulted in delayed
burn wound healing. We therefore propose that P311 is
a novel regulator of the transdifferentiation of EpSCs
during skin wound healing (Fig. 7b).
In skin, the majority of research on EMT has focused
on tumor progression and skin fibrosis, while only a
few studies have shown that EMT may be involved in
wound healing [34]. Although EpSCs act as one of the
main functional cells in wound healing, it is unclear
whether and how EpSCs transdifferentiate into myofi-
broblasts or MFLCs. In this study, our results indicated
that EpSCs were capable of transdifferentiating into
MFLCs in vitro and that this process might be regu-
lated by P311. P311-expressing mouse and human
EpSCs lost their typical cobblestone morphology and
exhibited a myofibroblast-like fusiform morphology.
Moreover, P311 upregulated myofibroblast markers
(such as vimentin and α-SMA) and downregulated
EpSC markers (such as β1-integrin and E-cadherin).
Moreover, P311 reorganized the cortical cytoskeleton
into filamentous stress fibers. However, functional tests
showed that P311 promoted the EpSC migration and
the collagen I and MMP2 expression but did not enable
EpSCs to develop strong contractility (Additional file 2:
Figure S5). One possible explanation for this result is
that the EMT program involving P311 might be limited
to the early myogenic program, although P311 could
induce other programs, such as de-epithelialization (via
the loss of E-cadherin), fibrogenesis (via vimentin and
collagen I), possible disruption of the basement mem-
brane (via MMP2), and enhanced cell migration. Another
possible explanation is that, as reported previously
(Additional file 1: Table S2), EMT-sourced myofibroblasts
might become the MFLCs that mainly feature motility
and secretory abilities, but that are not the same as the
classic myofibroblasts which feature both contractility and
secretory abilities. Furthermore, we show here that the
physiological significance of EpMyT is to enable EpSCs to
secrete collagen I and MMP2 and obtain a higher degree
of motility [35], but not to generate contractions. Hence,
in this study, we defined the transdifferentiated EpSCs as
MFLCs to distinguish from the typical myofibroblasts.
More studies are needed to determine the mechanisms
underlying this interesting phenomenon.
In this study, we found that P311 may activate and amp-
lify TGFβ1/Smad signaling in EpSCs. Specifically, the
phosphorylation of Smad2 and Smad3 was increased in
P311-overexpressing EpSCs and decreased in the P311
KO EpSCs. To conclusively confirm the role of TGFβ1/
Smad signaling in P311-induced EpMyT, loss-of-function
and rescue strategies were used. LY2109761, a specific
inhibitor of TβRII and TβRI, and the specific Smad3
siRNA almost completely blocked P311-induced EpMyT.
Furthermore, the application of exogenous TGFβ1 re-
stored EpMyT in P311 KO EpSCs. The level of α-SMA
expression dropped only slightly in P311 KO cells, and ex-
ogenous TGFβ1 had a smaller effect on α-SMA in P311
KO cells, suggesting that other factors (such as Rock path-
way) may also contribute to this process. These inhibition
and rescue experiments further support our hypothesis
that P311 promotes EpMyT partly via a TGFβ1-mediated
signaling.
The role of and mechanisms involving P311 in the
expression of TGFβ1 might be cell specific. In NIH3T3
fibroblasts, P311 inhibited the production of the TGFβ1
mRNA and protein at the post-translational level. Specif-
ically, P311 bound to LAP, which led to a decrease in
TGFβ1 auto-induction [36]. In vascular smooth muscle
cells, P311 inhibited the transcription of the TGFβ1
mRNA but promoted the production of the TGFβ1 pro-
tein at the translational level. In particular, P311 directly
bound to the 5′ UTRs of TGFβ1 and eIF3b to stimulate
the translation of TGFβ1 [24, 37]. However, these data
do not fully explain the observed decrease in TGFβ1
mRNA levels, and the mechanism by which P311 regu-
lates TGFβ1 in EpSCs remains unclear. Our results show
that the decrease in TGFβ1 mRNA levels and the increase
in TGFβ1 protein levels observed in P311-overexpressing
EpSCs are most likely caused by the inhibition of its tran-
scription, which is the result of enhanced promoter
methylation and the improved translation of activated
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5′ and 3′ UTRs. The current study therefore indicates
that P311 regulates TGFβ1 expression not only at the
translational level but also at the transcriptional level.
This conclusion is also partly supported by our recent
finding that eIF6, a partner of P311, downregulates
TGFβ1 mRNA and protein expression levels at the
transcriptional level via H2A.Z occupancy and Sp1 re-
cruitment in fibroblasts [38]. However, further studies
are needed to determine the mechanism by which P311
enhances the methylation of the TGFβ1 promoter and
which specific sites of the TGFβ1 5′/3′ UTRs are
bound by P311.
In-vivo experiments provided indirect and weak
evidence showing that P311 mediates the induction of
EpMyT. P311+α-SMA+ cells and P311+vimentin+ cells
were observed in the epidermis of human burn wounds.
Furthermore, the mesenchymal features of these cells
were reduced in the P311 KO mouse burn wounds. In
this study, we found that superficial second-degree
thermal burn wounds in mice healed within 10 days
and α-SMA+ cells were not detected in the epidermis of
these mice, consistent with the results of previous studies
[14, 15]. However, the burn wounds obtained from pa-
tients who needed skin graft surgery healed slower than
the mouse wounds, and α-SMA+ cells were observed in
the wounds of these patients. Interestingly, α-SMA has
also been detected in the epidermis of the wounds of
Buruli ulcer patients [39]. Thus, given the results of this
study, we concluded that the severity of the injury and
the length of time required for wound healing might be
related to α-SMA expression. However, there are nat-
ural limitations to the detection methods that were
used in this study. For example, histological “snapshots”
can potentially show nonspecifically bound antibodies,
and using full-thickness skin samples means that the
mRNA and protein detection methods utilized do not ex-
clude a contribution of the dermis. As a result, we could
not determine whether the α-SMA+ cells or vimentin+
cells did indeed originate from EpSCs in vivo or whether
EpMyT was actually reduced in P311 KO mice. Our re-
sults only hint that P311 might have a possible relation-
ship with the mesenchymal features of the epidermis in
vivo. However, the in-vitro experiments provide direct
evidence showing that P311 induced EpMyT. To
strengthen the evidence for EpMyT induction in vivo,
new fate-mapping studies are needed, and related re-
search is currently being performed in our program.
Cytokines, growth factors, and EMT-related transcrip-
tion factors are the main reported regulators of EMT
[40]. In this study, the relationship between P311 and
other EMT inducers (which are also common injury sig-
nals), including IL-1β [15], IL-6 [41], TNFα [15], and
hypoxia [42], were also investigated. Our results showed
that P311 expression was elevated by the investigated
injury and EMT inducers, especially IL-1β and TNFα.
These results indicate that P311 might be a common
pathway for cytokine-induced EMT, and our study adds
novel regulators of P311 to previously reported results
in the kidney and neural and smooth muscle cells. How-
ever, identifying the mechanisms underlying these pro-
cesses requires further study.
Conclusions
In summary, this work provides the first evidence showing
that P311 is a novel regulator of the potential for EpSCs to
transdifferentiate into MFLCs and that this mechanism is
mediated by TGFβ1/Smad signaling. Moreover, we dem-
onstrate that P311 might stimulate TGFβ1 expression by
promoting TGFβ1 promoter methylation at the transcrip-
tional level and by activating TGFβ1 5′/3′ UTRs at the
translational level. Furthermore, P311 might be induced
by cytokines and hypoxia, and deletion of P311 resulted in
delayed burn wound healing. Thus, we identify the P311–
TGFβ1 axis as a novel regulator for transdifferentiation of
EpSCs during cutaneous wound healing.
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